A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults | MicrobiomeTrials
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2024-06-16Est. Completion: 2026-01-26
Enrollment target: 112 participants
Locations
Centre for the Evaluation of Vaccination (CEV), Antwerp, Belgium
University Hospital Ghent - Centrum voor Vaccinologie (CEVAC), Ghent, Belgium
Other microbiome trials you might be interested in